Agronomist engineer Ana Paula Porfírio, head of the Social Participation and Diversity Advisory of the Ministry of Agriculture and Livestock (MAPA), and researcher Beatriz Emydio, from Embrapa, will participate in the panel “Cannabis in Brazil: Challenges and Perspectives of Post-Regulation Cultivation”

Bloomberg speculates on the reasons leading the country to this process of recriminalization

National survey ENCODAT 2025 reveals new consumption patterns and will support public health policies

Colombian producers urge 'urgent' regulation for adult use, which they believe will benefit public health and reduce the violence stemming from the illicit market

Unanimous decision by the Fifth Panel reinforces patients' right to therapeutic planting upon medical proof and highlights the topic in an official report

In Argentina, marijuana is legal only for medicinal use. Since the enactment of Law 27.350 in 2017, the country allows the use of cannabis for therapeutic purposes under a strict regulatory framework.

The decree establishes procedures for the industrial use of cannabis in the food, beverage, and textile sectors.

After receiving an action plan from the Union, the 1st Section of the STJ extends the deadline for delivering regulations on the production and access to cannabis for medicinal use

Court relied on Anvisa resolution to justify favorable opinion

Denmark has officially approved a law that makes its medicinal cannabis pilot program permanent, integrating it into the national healthcare system. The measure was celebrated as a 'victory for patients'

Spain has banned HHC and other cannabinoids. See what has changed with the new law, the affected substances, and what this reveals about the future of cannabis.

São Paulo hosts, on Thursday (06), the main meeting point for the Medicinal and Industrial Cannabis industry in Latin America

Decision of the TJDFT obliges the local government to maintain the supply of cannabis-based medications, even if not on the SUS list

Unrestricted prohibitions on Cannabis products currently in force are not in line with Anvisa's regulatory microsystem.

New legislation regulates production, tracking, and distribution of low-THC products for therapeutic use

Reform sets a 1% THC limit, allows the supply of biomass for medicinal purposes, and replaces mandatory licensing with a simple notification system, foreseeing an economic impact of 41 million dollars

Minister Regina Helena Costa states that this will be the last extension and orders Anvisa to report compliance with each intermediate step of the plan

Public hearing discusses legal support for entities that cultivate and distribute cannabis for therapeutic purposes

"$170 Million Market at Risk." Strict regulations could collapse the medicinal industry in the country, experts suggest

Semillas Endemicas Mexicanna receives authorization for the cultivation and processing of industrial hemp, while the country awaits specific regulations